Skip to main content
logo
TILT Holdings Inc. (TLLTF)
OTCMKTS · Delayed Price · Currency is USD
0.0098
+0.0028 (39.86%)
Aug 14, 2025, 10:32 AM EDT

Revance Therapeutics Revenue

TILT Holdings had revenue of $22.73M in the quarter ending March 31, 2025, a decrease of -39.41%. This brings the company's revenue in the last twelve months to $100.84M, down -37.45% year-over-year. In the year 2024, TILT Holdings had annual revenue of $115.61M, down -30.33%.

Revenue (ttm)
100.84M
Revenue Growth
-37.45%
P/S Ratio
0.03
Revenue / Employee
332.79K
Employees
313
Market Cap
2.84M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024115.61M-50.34M-30.33%
Dec 31, 2023165.96M-8.23M-4.73%
Dec 31, 2022174.19M-28.52M-14.07%
Dec 31, 2021202.71M44.30M27.96%
Dec 31, 2020158.41M11.47M7.81%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Veradigm588.02M
Tian'an Technology Group1.78M
Elite Pharmaceuticals84.04M
Glass House Brands215.62M
American Oncology Network1.76B
Northwest Biotherapeutics1.47M
Silence Therapeutics27.17M
Global Cord Blood196.10M
Revenue Rankings

TILT Holdings News

More News